Irwin Naturals
Steel-Libido
Serving
4 Softgel(s)
Per container
18
Form
capsule-unknown
UPC
710363262389
DSLD
Formula hash
b62dacdc9de0
Brand context
Catalog
314
products
With avoid flag
269
products
FDA recalls
0
history
CAERS
12
reports
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
11
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.
Supplement Facts
11 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| L-Arginine Arginineamino_acidUNII · 94ZLA3W45F | 335 mg | — |
| Maca powder Macaherb | 260 mg | — |
| Ashwagandha powder Ashwagandhaherb LiverTox B | 240 mg | — |
| Epimedium extract Epimediumherb | 240 mg | — |
| Tribulus extract TribulusherbUNII · 4X4HLN92OT | 240 mg | — |
| Dimethylglycine herb | 160 mg | — |
| Yohimbe extract YohimbeherbUNII · 9M051HS3S5 | 140 mg | — |
| L-Tyrosine Tyrosineamino_acidUNII · 42HK56048U | 120 mg | — |
| CDP-Choline Citicolineherb | 100 mg | — |
| Bioperine Complex (Herb/Botanical) Proprietary Blend (Herb/Botanical)other | 20 mg | — |
| Nicotinamide Adenine Dinucleotide herbUNII · 0U46U6E8UK | 1 mg | — |
Flagged excipients
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
FDA CAERS · adverse event context
11
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Other ingredients
Soybean Oil · Gelatin · purified Water · Glycerin · Beeswax · Lecithin · Caramel · St. John’s Bread